BR0213172A - Amida do ácido 8-amino-[1,2,4]triazolo[1,5-a]piridina-6-carboxìlico - Google Patents
Amida do ácido 8-amino-[1,2,4]triazolo[1,5-a]piridina-6-carboxìlicoInfo
- Publication number
- BR0213172A BR0213172A BR0213172-2A BR0213172A BR0213172A BR 0213172 A BR0213172 A BR 0213172A BR 0213172 A BR0213172 A BR 0213172A BR 0213172 A BR0213172 A BR 0213172A
- Authority
- BR
- Brazil
- Prior art keywords
- lower alkyl
- pyridine
- amino
- carboxylic acid
- acid amide
- Prior art date
Links
- UCKNLYIWMXSNJK-UHFFFAOYSA-N 8-amino-[1,2,4]triazolo[1,5-a]pyridine-6-carboxamide Chemical compound C1=C(C(=O)N)C=C(N)C2=NC=NN21 UCKNLYIWMXSNJK-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 102000000506 Adenosine A2 Receptors Human genes 0.000 abstract 1
- 108010041368 Adenosine A2 Receptors Proteins 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000006574 non-aromatic ring group Chemical group 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- IBBMAWULFFBRKK-UHFFFAOYSA-N picolinamide Chemical compound NC(=O)C1=CC=CC=N1 IBBMAWULFFBRKK-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Addiction (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01123948 | 2001-10-08 | ||
| PCT/EP2002/011152 WO2003030904A1 (en) | 2001-10-08 | 2002-10-04 | 8-amino-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylic acid amide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0213172A true BR0213172A (pt) | 2004-09-14 |
Family
ID=8178876
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0213172-2A BR0213172A (pt) | 2001-10-08 | 2002-10-04 | Amida do ácido 8-amino-[1,2,4]triazolo[1,5-a]piridina-6-carboxìlico |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6689790B2 (enExample) |
| EP (1) | EP1435952A1 (enExample) |
| JP (1) | JP4101755B2 (enExample) |
| KR (1) | KR100614486B1 (enExample) |
| CN (1) | CN1564686A (enExample) |
| AR (1) | AR036734A1 (enExample) |
| AU (1) | AU2002347055B2 (enExample) |
| BR (1) | BR0213172A (enExample) |
| CA (1) | CA2462806A1 (enExample) |
| MX (1) | MXPA04003277A (enExample) |
| PL (1) | PL370067A1 (enExample) |
| RU (1) | RU2296763C2 (enExample) |
| WO (1) | WO2003030904A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009259853A1 (en) * | 2008-06-20 | 2009-12-23 | Genentech, Inc. | Triazolopyridine JAK inhibitor compounds and methods |
| PE20110063A1 (es) * | 2008-06-20 | 2011-02-16 | Genentech Inc | DERIVADOS DE [1, 2, 4]TRIAZOLO[1, 5-a]PIRIDINA COMO INHIBIDORES DE JAK |
| TWI453207B (zh) * | 2008-09-08 | 2014-09-21 | Signal Pharm Llc | 胺基三唑并吡啶，其組合物及使用其之治療方法 |
| US8283465B2 (en) * | 2009-07-17 | 2012-10-09 | Japan Tobacco Inc. | Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor or erythropoietin production-inducing agent |
| ES2558618T3 (es) * | 2012-02-09 | 2016-02-05 | F. Hoffmann-La Roche Ag | Procedimiento para la preparación de derivados 2-fenil-[1,2,4]triazolo[1,5-A]piridina |
| US9048427B2 (en) * | 2013-03-06 | 2015-06-02 | National Tsing Hua University | Thin film fabrication of rubber material with piezoelectric characteristics |
| JP6327483B2 (ja) * | 2013-05-31 | 2018-05-23 | 日産化学工業株式会社 | 複素環アミド化合物 |
| CN104370807B (zh) * | 2014-11-13 | 2016-10-05 | 安徽星宇化工有限公司 | 一种6-羟基-5-硝基烟酸的合成方法及其分离提纯方法 |
| KR20200140849A (ko) | 2018-04-08 | 2020-12-16 | 베이진 엘티디 | A2a 수용체 길항제로서의 피라졸로트리아졸로피리미딘 유도체 |
| CN110742893B (zh) * | 2018-07-23 | 2024-04-05 | 百济神州(北京)生物科技有限公司 | A2a受体拮抗剂治疗癌症的方法 |
| WO2020054712A1 (ja) * | 2018-09-12 | 2020-03-19 | 日本化薬株式会社 | 有害生物防除剤 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE287263C (enExample) * | ||||
| HU208693B (en) * | 1991-02-22 | 1993-12-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing 1,2,4-triazolo (1,5-a) pyrimidinis derivatives and their carbicycli-tetrahydro-thiofurane-tetrahydrothiopyrane-, or tetrahydropyridine- condensated derivatives or medical preparatives containing them |
| ES2135062T3 (es) * | 1994-06-16 | 1999-10-16 | Pfizer | Pirazolo y pirrolopiridinas. |
| WO1998042711A1 (en) * | 1997-03-24 | 1998-10-01 | Kyowa Hakko Kogyo Co., Ltd. | [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES |
| US6355653B1 (en) * | 1999-09-06 | 2002-03-12 | Hoffmann-La Roche Inc. | Amino-triazolopyridine derivatives |
| US6506772B1 (en) * | 2000-12-15 | 2003-01-14 | Hoffmann-La Roche Inc. | Substituted [1,2,4]triazolo[1,5a]pyridine derivatives with activity as adenosine receptor ligands |
-
2002
- 2002-10-04 BR BR0213172-2A patent/BR0213172A/pt not_active IP Right Cessation
- 2002-10-04 CN CNA02819912XA patent/CN1564686A/zh active Pending
- 2002-10-04 AU AU2002347055A patent/AU2002347055B2/en not_active Ceased
- 2002-10-04 EP EP02782832A patent/EP1435952A1/en not_active Withdrawn
- 2002-10-04 KR KR1020047005091A patent/KR100614486B1/ko not_active Expired - Fee Related
- 2002-10-04 JP JP2003533936A patent/JP4101755B2/ja not_active Expired - Fee Related
- 2002-10-04 WO PCT/EP2002/011152 patent/WO2003030904A1/en not_active Ceased
- 2002-10-04 RU RU2004114278/04A patent/RU2296763C2/ru not_active IP Right Cessation
- 2002-10-04 AR ARP020103749A patent/AR036734A1/es unknown
- 2002-10-04 PL PL02370067A patent/PL370067A1/xx not_active Application Discontinuation
- 2002-10-04 MX MXPA04003277A patent/MXPA04003277A/es active IP Right Grant
- 2002-10-04 CA CA002462806A patent/CA2462806A1/en not_active Abandoned
- 2002-10-07 US US10/265,957 patent/US6689790B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR20040048940A (ko) | 2004-06-10 |
| AR036734A1 (es) | 2004-09-29 |
| MXPA04003277A (es) | 2004-07-23 |
| JP4101755B2 (ja) | 2008-06-18 |
| CA2462806A1 (en) | 2003-04-17 |
| RU2296763C2 (ru) | 2007-04-10 |
| AU2002347055B2 (en) | 2006-10-12 |
| WO2003030904A1 (en) | 2003-04-17 |
| CN1564686A (zh) | 2005-01-12 |
| PL370067A1 (en) | 2005-05-16 |
| EP1435952A1 (en) | 2004-07-14 |
| JP2005508942A (ja) | 2005-04-07 |
| RU2004114278A (ru) | 2005-10-27 |
| US20030207911A1 (en) | 2003-11-06 |
| KR100614486B1 (ko) | 2006-08-22 |
| US6689790B2 (en) | 2004-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2862375B2 (ja) | Ｃｒｆアンタゴニストとしてのピラゾロピリミジン | |
| RU2204553C2 (ru) | 1,8-аннелированные производные хинолинона, замещенные n- или c-связанными имидазолами, ингибирующие фарнезилтрансферазу | |
| ES2251405T3 (es) | Derivados de benzodiazepina, su obtencion y aplicacion. | |
| FI91401B (fi) | Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi | |
| KR890005105A (ko) | 벤즈이미다졸린-2-옥소-1-카복실산 유도체 | |
| BG103785A (en) | Pyrrolo[2,3-d]pyrimidines and their application as tyrosine kinase inhibitors | |
| BR0013952A (pt) | Pteridinonas como inibidores de cinase | |
| MXPA98000415A (en) | Quimi compounds | |
| DE69110320D1 (de) | Stickstoff enthaltende heterozyklische Verbindungen, ihre Herstellung und Verwendung. | |
| ATE139233T1 (de) | Annelierte thiophen-derivate, ihre herstellung und verwendung | |
| HUP0402324A2 (hu) | [1,2,4]-Triazolo[1,5-a]piridin- és [1,2,4]triazolo[1,5-c]pirimidin-származékok mint adenozin A2a receptor antagonisták és az ezeket tartalmazó gyógyszerkészítmények | |
| HUP0204429A2 (hu) | Aril-amin-származékok és alkalmazásuk antitelomeráz hatású szerként | |
| FI97544B (fi) | Menetelmä lääkeaineina käyttökelpoisten 1-(pyrido/3,4-b/-1,4-oksatsin-4-yyli)-1H-indolien valmistamiseksi | |
| ZA200306108B (en) | Beta-carboline derivatives and its pharmaceutical use against depression and anxiety. | |
| PL173540B1 (pl) | Podstawione (pirydynoamino)benzizoksazole i sposób wytwarzania podstawionych (pirydynoamino)benzizoksazoli | |
| CZ20024054A3 (cs) | Derivát 5-aminoalkylpyrazolo[4,3-d]pyrimidinu, způsob jeho přípravy, jeho použití a léčivo, které ho obsahuje | |
| AR036734A1 (es) | Derivados de 8-amino-[1,2,4]triazolo[1,5-a]piridina-6-carboxilico | |
| Bagli et al. | Chemistry and positive inotropic effect of pelrinone and related derivatives. A novel class of 2-methylpyrimidones as inotropic agents | |
| EP0163240A2 (en) | Dihydroimidazo[1,2-a]pyrimidine derivatives, methods of preparing said compounds and pharmaceutical compositions constaining said compounds | |
| BR0213177A (pt) | Derivados de 5-metóxi-8-aril-[1,2,4]triazolo[1,5-a]piridina | |
| NO931342L (no) | Benzimidazoler, medisinske preparater inneholdende disse,og fremgangsmaate for deres fremstilling | |
| DK1303514T3 (da) | Fremgangsmåde til fremstilling af azacycloalkanoylaminothiazoler | |
| DE3786109D1 (de) | Pyrido(2,3-d)pyrimidin-derivate. | |
| MXPA02011464A (es) | Derivados 1,4-diazepan-2,5-diona y su uso como antagonistas del receptor de la nk-1. | |
| DK169704B1 (da) | Imidazoquinolinderivater, sådanne derivater til anvendelse som et anti-ulcusmiddel eller til behandling af hypersekretion samt farmaceutisk præparat indeholdende sådanne derivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE A 8.6, DA RPI 2108 DE 31/05/2011. |